(Press-News.org) PHILADELPHIA, PA (May 16, 2011)––Today's anticancer drugs often work wonders against malignancies, but sometimes tumors become resistant to the effects of such drugs, and treatment fails. Medical researchers would like to find ways of counteracting such resistance, but first they must understand why and how it happens. New findings by Fox Chase Cancer Center researchers identify one protein, Abcc10 (also known as Mrp7), as being intimately involved in resistance to certain drugs used to treat breast, ovarian, lung, and other cancers. The results suggest that blunting the activity of Abcc10 might help counter resistance and extend the effectiveness of these anticancer drugs.
The findings appear in the May 16, 2011 issue of the journal Cancer Research.
In earlier work, Elizabeth A. Hopper-Borge, Ph.D., an assistant professor at Fox Chase, showed that Abcc10 confers resistance to a number of anticancer agents, particularly taxanes, which include paclitaxel (Taxol) and docetaxel (Taxotere). These drugs––originally derived from the Pacific yew tree––work by disrupting cell division, thus arresting the growth and spread of tumors. The initial finding that Abcc10, a member of a ubiquitous family of proteins called ATP-binding cassette transporters, thwarts taxanes' anti-tumor activity was something of a surprise, says Hopper-Borge, because none of the other family members seem to have that ability.
In the new research, Hopper-Borge and colleagues wanted to further explore, in both cultured cells and mice, the role of Abcc10. They developed a "knockout" mouse, in which the gene that codes for Abcc10 was missing, or knocked out. These mice appeared normal and healthy in every other respect, suggesting that Abcc10 is not essential for overall health and survival.
The researchers isolated cells from the knockout mice and tested the cells' reactions to taxanes and two other anticancer drugs, vincristine and Ara-C. Compared to cells from normal mice that still possessed the gene for Abcc10, the knockout mouse cells were much more sensitive to the drugs.
Abcc10 and its ilk work by pumping drugs out of cells, so one might expect to see the drugs accumulating in cells that lack Abcc10, and that's exactly what Hopper-Borge's group saw. It had been suggested that other proteins might take over for Abcc10 if that protein were knocked out, but the researchers found no evidence suggesting that had happened.
Next, the research team studied the effects of one particular taxane, paclitaxel, on mice and found that the knockout mice were more sensitive to the drug, as reflected in body weight, white blood cell count, and ability to survive escalating doses of the drug.
"After seeing the effects on white blood cells, we decided to look at the tissue types that produce white blood cells to see if we could actually see differences there," says Hopper-Borge. As expected, knockout mice treated with paclitaxel had smaller spleens and thymus glands and underdeveloped bone marrow, compared to normal mice treated with the same drug.
The results provide the first evidence from living organisms that Abcc10 is a cell's built-in protection against the effects of powerful drugs, and raises the possibility of using Abcc10 inhibitors to break down that resistance and sensitize tumor cells to anticancer agents. The fact that mice lacking the protein have no obvious health problems is encouraging, suggesting that Abcc10 inhibitors could be used in human patients without causing side effects that might be expected to result from interfering with the pump's normal functions.
Several Abcc10 inhibitors already have been identified, but they also inhibit other cellular transporters, which could have deleterious effects. For that reason, Hopper-Borge thinks the best approach may be developing inhibitors that work only in tumor cells or coming up with compounds that modulate, rather than completely inhibit the protein's activity.
But using such treatments in patients is still far in the future, she emphasizes.
"I'd like to stress that we did this work in a mouse model," Hopper-Borge says. "Our results so far suggest that this protein may be a clinically relevant target, but we need to do more studies to find out for sure."
###
Co-authors on the study include Timothy Churchill, Chelsy Paulose, Emmanuelle Nicolas, Joely D. Jacobs, Olivia Ngo, Andres J. Klein-Szanto and Martin G. Belinsky of Fox Chase; Yehong Kuang of Central South University, Changsha, China; Alex Grinberg and Heiner Westphal of the National Institute of Child Health and Human Development; and Gary D. Kruh of the University of Illinois at Chicago.
The research was supported by the National Institutes of Health.
Fox Chase Cancer Center is one of the leading cancer research and treatments centers in the United States. Founded in 1904 in Philadelphia as one of the nation's first cancer hospitals, Fox Chase was also among the first institutions to be designated a National Cancer Institute Comprehensive Cancer Center in 1974. Fox Chase researchers have won the highest awards in their fields, including two Nobel Prizes. Fox Chase physicians are also routinely recognized in national rankings, and the Center's nursing program has received the Magnet status for excellence three consecutive times. Today, Fox Chase conducts a broad array of nationally competitive basic, translational, and clinical research, with special programs in cancer prevention, detection, survivorship, and community outreach. For more information, call 1-888-FOX-CHASE or 1-888-369-2427.
END
Durham, N.C., and Singapore – Mast cells, which can help the body respond to bacteria and pathogens, also apparently sound the alarm around viruses delivered by a mosquito bite, according to researchers at Duke-NUS Graduate Medical School in Singapore.
"It appears the mast cells are activated and call immune system cells to the skin where they clear infection, which limits the spread of infection in the host," said lead researcher Ashley St. John, a Research Fellow with Duke-NUS in the Program in Emerging Infectious Diseases, and the Duke Department of Pathology in Durham, ...
With an increasingly warmer climate, there is a trend for springs to arrive earlier and summers to be hotter. Since spring and summer are the prime growing seasons for plants—when flowers bloom and trees increase in girth and height—do these climate changes mean greater seasonal growth for plants? This is a critical question for forest management, especially in the boreal region—an area particularly sensitive to the effects of climate change.
Dr. Jian-Guo Huang, currently a post-doc at the University of Alberta, and colleagues from the University of Quebec at Montreal ...
Scientists working with Professor Dr. Joachim L. Schultze have identified over 480 molecules whose concentration in the blood changes when a person develops lung cancer. These molecules are present in the blood cells either in increased or decreased quantities. "In lung cancer patients, typical patterns which can be detected with a measuring program thus emerge", explains Prof. Schultze. The molecules are nucleic acids which form in the body when certain genes are transcribed.
The changes in the blood also occur if the tumor is still in a very early stage. In lung cancer, ...
Patients with heart disease risks are more likely to be prescribed cardiovascular (CV) drugs if they see a younger doctor and recommended to change their lifestyle if they see an older doctor, according to research in the June issue of IJCP, the International Journal of Clinical Practice.
Italian researchers studied the attitudes and prescribing trends of 1,078 family doctors, cardiologists and diabetologists, together with clinical data on 9,904 of their outpatients, after inviting the doctors to take part in an educational training programme on managing CV risk.
"While ...
Aggressive male mating behavior might well be a successful reproductive strategy for the individual but it can drive the species to extinction, an international research team headed by evolutionary biologist Daniel Rankin from the University of Zurich has demonstrated in a mathematical model.
Evolutionary biologists have long debated whether the behavior of the individual is able to influence processes on a population or species level. The possibility of selection at species level is still contro-versial. Using a mathematical model, an international team of researchers ...
These scientists have developed a mathematical model that recreates the behavior of an ecosystem in order to observe its dynamics and its reactions in different situations. And what they have discovered is that the ecosystem reaches a state in which it remains more or less unchanged, in spite of the fact that the species that make it up are continuously substituted by others, even to the point that a complete change takes place, similar to the change that occurs inside a human organism. "In short: the species change, but the structure does not", comments Professor José ...
Most solid materials are composed of millions of small crystals, packed together to form a fully dense solid. The orientations, shapes, sizes and relative arrangement of these crystals are important in determining many material properties.
Traditionally, it has only been possible to see the crystal structure of a material by looking at a cut surface, giving just 2D information. In recent years, x-ray methods have been developed that can be used to look inside a material and obtain a 3D map of the crystal structure. However, these methods have a resolution limit of around ...
Sophia Antipolis, France, Sunday 15 May 2011: The European Society of Cardiology (ESC) is calling for a single, co-ordinated European system to oversee the evaluation and approval of medical devices. The call is being made in a paper published online in the European Heart Journal reporting on a conference held by the ESC in January 2011 looking to increase the input of medical experts in developing medical device policy.
"The ESC believes that the approval of devices used in medicine shares similarities in terms of ethical responsibilities as the approval of new ...
The research aircraft Polar 5 of the Alfred Wegener Institute for Polar and Marine Research in the Helmholtz Association returned to Bremerhaven from a six-week expedition in the high Arctic on May 6. Joint flights with aircraft of the European and American space agencies (ESA and NASA) were a novelty in sea ice research: Simultaneous measurements with a large number of sensors on three planes underneath the CryoSat-2 satellite led to unique data records. Furthermore, the international team composed of 25 scientists and engineers collected data on trace gases, aerosols ...
A new study offers hope for species such as the Siberian Tiger that might be considered 'too rare to save', so long as conservation efforts can target key threats.
The findings have important implications for conserving some of the world's most charismatic endangered species, which often exist in populations far smaller than the many thousands of individuals that earlier studies had argued were necessary for viability.
Charismatic examples include the mountain gorilla, which likely now number 1,000 or less, the approximately 450 remaining Amur or Siberian tigers, ...
